2015
Targeting the Noradrenergic System for Gender-Sensitive Medication Development for Tobacco Dependence
Verplaetse TL, Weinberger AH, Smith PH, Cosgrove KP, Mineur YS, Picciotto MR, Mazure CM, McKee SA. Targeting the Noradrenergic System for Gender-Sensitive Medication Development for Tobacco Dependence. Nicotine & Tobacco Research 2015, 17: 486-495. PMID: 25762760, PMCID: PMC4432402, DOI: 10.1093/ntr/ntu280.Peer-Reviewed Original ResearchConceptsSmoking cessationNoradrenergic systemClinical evidenceTobacco dependenceNoradrenergic activityMedication developmentPoor smoking cessation outcomesCause of morbiditySmoking cessation outcomesStress reactivitySex-specific mechanismsLower quit ratesNicotine-related reinforcementCurrent medicationsMedication effectivenessNicotine reinforcementCessation outcomesNoradrenergic agentsQuit ratesTreatment strategiesTobacco useNoradrenergic compoundsSmoking outcomesTreatment developmentWomen
2010
Differences in smoking expectancies in smokers with and without a history of major depression
Weinberger AH, George TP, McKee SA. Differences in smoking expectancies in smokers with and without a history of major depression. Addictive Behaviors 2010, 36: 434-437. PMID: 21239119, PMCID: PMC3052745, DOI: 10.1016/j.addbeh.2010.12.024.Peer-Reviewed Original ResearchConceptsHistory of depressionMajor depressive disorderSmoking cessationClinical trialsSmoking expectanciesAdult cigarette smokersInteraction of depressionSmoking cessation behaviorsLower quit ratesMDD- smokersCigarette smokersDepressive disorderAdult smokersCognitive-behavioral treatmentMajor depressionQuit ratesCessation behaviorsSmokersSelegiline hydrochlorideSmokingSecondary aimEvidence high ratesDepressionSmoking beliefsHigh rate